Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 7/20 | 0.44 |
| ▸ | PPARA | Q07869 | 7/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11792119 | 0.98 | AKR1B1 (0.44) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL129475 | 0.93 | DGKA (0.39) | AKR1B1GPR84TSHRALDH1A1SLC22A6 | |
| SCHEMBL158234 | 0.92 | AKR1B1 (0.53) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5864689 | 0.92 | AKR1B1 (0.48) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL22444199 | 0.92 | AKR1B1 (0.53) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL9452097 | 0.91 | GPR84 (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL11762845 | 0.91 | GPR84 (0.50) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL19471289 | 0.90 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5701165 | 0.90 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL182514 | 0.90 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-3357485-B1 | SUNSCREEN COSMETIC | SHISEIDO CO LTD (JP) | 2026-05-27 | — | — | EP | claimed |
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | claimed |
| US-20250269034-A1 | TOPICAL TETRACYCLINE COMPOSITIONS | JOURNEY MEDICAL CORP (US) | 2025-08-28 | — | — | US | claimed |
| WO-2025075986-A9 | HYDROGEL ORAL DELIVERY SYSTEMS AND METHODS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-05-15 | — | — | WO | claimed |
| US-20250134875-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | THIRONA BIO, INC. (US) | 2025-05-01 | — | — | US | claimed |
| WO-2025090562-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | THIRONA BIO, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075986-A1 | HYDROGEL ORAL DELIVERY SYSTEMS AND METHODS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-10 | — | — | WO | claimed |
| US-20240374491-A1 | COSMETIC COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2024-11-14 | — | — | US | claimed |
| US-12138311-B2 | Topical tetracycline compositions | JOURNEY MEDICAL CORPORATION (US) | 2024-11-12 | — | — | US | claimed |
| WO-2011039638-A2 | TOPICAL TETRACYCLINE COMPOSITIONS | FOAMIX LTD. (IL) | 2011-04-07 | — | — | WO | claimed |
| WO-2011039637-A2 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | FOAMIX LTD. (IL) | 2011-04-07 | — | — | WO | claimed |
| EP-2301522-A1 | WATER-IN-OIL EMULSION-TYPE COSMETIC PREPARATION | SHISEIDO CO., LTD. (JP) | 2011-03-30 | — | — | EP | claimed |
| EP-2288416-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO Industries, Inc. (US) | 2011-03-02 | — | — | EP | claimed |
| WO-2009058802-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO INDUSTRIES, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-7060301-B2 | In situ mono-or diester dicarboxylate compositions | ECOLAB INC. (US) | 2006-06-13 | — | — | US | claimed |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | L'OREAL S.A. (FR) | 2004-11-25 | — | — | US | claimed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | claimed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | claimed |
| US-3976427-A | Organic compounds | SANDOZ LTD. (CH) | 1976-08-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250134875-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | ALK, ACVR1, ACVRL1 | AKR1B1 835/4885GPR84 1140/4885PPARG 1761/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | AKR1B1 912/4885GPR84 800/4885PPARG 484/4885 |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | CUTA, AUP1, PLIN3 | AKR1B1 1396/4885GPR84 2454/4885PPARG 52/4885 |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | AKR1B1 848/4885GPR84 643/4885PPARG 818/4885 |
| US-20240374491-A1 | COSMETIC COMPOSITION | TYR, MITF, ACOX1 | AKR1B1 449/4885GPR84 720/4885PPARG 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.